Savara Inc

Затворен

СекторЗдравеопазване

4.59 6.74

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

4.18

Максимум

4.51

Ключови измерители

By Trading Economics

Приходи

-2.9M

-40M

EPS

-0.16

Служители

70

EBITDA

-2.9M

-40M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+150.74% upside

Дивиденти

By Acuity

Следващи печалби

10.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-223M

951M

Предишно отваряне

-2.15

Предишно затваряне

4.59

Savara Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

26.10.2026 г., 23:56 ч. UTC

Savara Inc's shares advanced in after-market trading, reflecting a notable rise since Monday's close, though still below its 20-day moving average.

23.10.2026 г., 21:02 ч. UTC

Savara Inc shares advanced in after-market trading, reaching a high shortly after the market closed before settling to a more modest gain.

22.10.2026 г., 20:07 ч. UTC

News

Savara Inc's stock is declining after the company reiterated its Market Outperform rating and $10 price target, following new Molbreevi data presented at the CHEST conference.

21.10.2026 г., 23:16 ч. UTC

Savara Inc is trading higher in after-market hours, gaining since Wednesday's close.

20.10.2026 г., 23:06 ч. UTC

Savara Inc. shares advanced modestly in after-market hours, following a session that saw earlier peak gains before settling lower.

19.10.2026 г., 22:51 ч. UTC

Savara Inc shares are moving higher in after-market trading, supported by an upward trend in the broader market, despite earlier session pullbacks.

16.10.2026 г., 22:26 ч. UTC

Savara Inc shares traded lower in after-market hours, reflecting ongoing weakness amid broader market concerns over rising U.S. import and export prices.

15.10.2026 г., 23:06 ч. UTC

Savara Inc's shares are advancing in after-market trading, gaining ground since Thursday's close, with a cumulative return peaking at just under 1.9%.

14.10.2026 г., 19:36 ч. UTC

Savara Inc shares fell modestly on Wednesday, retracing from an early peak and remaining under pressure below their 20-day moving average.

13.10.2026 г., 20:13 ч. UTC

Savara Inc shares advanced in after-market trading, continuing their upward trend since Tuesday's close, though still below the 20-day moving average.

12.10.2026 г., 19:36 ч. UTC

Social Media

Savara Inc shares are declining, having pulled back from an earlier high in pre-market hours, and are currently below their 20-day moving average.

9.10.2026 г., 19:55 ч. UTC

Social Media

JPMorgan sets a price target of $12 for Savara Inc, noting catalysts including anticipated UK approval in Q4 and a MAA in Q1 for molgramostim.

8.10.2026 г., 23:25 ч. UTC

Savara Inc shares advanced during after-market hours on Thursday, settling at a solid gain.

7.10.2026 г., 20:01 ч. UTC

News
Social Media

Savara Inc shares are trading sharply higher as JP Morgan initiated coverage with an Overweight rating and a $12 price target ahead of its PDUFA date.

6.10.2026 г., 20:00 ч. UTC

Savara Inc shares fell, breaking a trend of higher daily closes, indicating a shift in momentum following Monday's close.

2.10.2026 г., 20:01 ч. UTC

Savara Inc shares fell sharply, experiencing significant volatility and trading below their 20-day moving average amid high market volume.

1.10.2026 г., 19:46 ч. UTC

Social Media

Savara Inc shares are trading lower as heightened short interest and increased volume coincide with the approach of its PDUFA date for molgramostim.

30.09.2026 г., 21:03 ч. UTC

Social Media

Savara Inc shares are trading higher in after-market hours amid speculation of a short squeeze ahead of its PDUFA date for molgramostim, with a market cap of $1 billion.

28.09.2026 г., 20:02 ч. UTC

Social Media

Savara Inc is trading higher amid notable social media activity and unusual options bets, with a PDUFA date set for November 22.

25.09.2026 г., 20:07 ч. UTC

Savara Inc shares fell sharply, continuing the downward trend with a cumulative return in negative territory and remaining below its 20-day moving average.

24.09.2026 г., 19:46 ч. UTC

Savara Inc is trading higher, having previously peaked before a slight retracement, though it remains below its 20-day moving average.

23.09.2026 г., 22:01 ч. UTC

Savara Inc gained in after-market trading following a brief decline earlier in the session, though it remains below its 20-day moving average.

22.09.2026 г., 20:05 ч. UTC

Savara Inc's stock is declining sharply, moving from an initial gain to a notable drop, trading below its 20-day moving average.

21.09.2026 г., 20:12 ч. UTC

Savara Inc is advancing in after-market trading, positioned above its 20-day moving average and near the upper end of its one-month range.

18.09.2026 г., 23:11 ч. UTC

Savara Inc is trading modestly higher in after-market hours, reflecting the broader market's upward movement, with notable gains since Friday's close.

17.09.2026 г., 23:11 ч. UTC

Savara Inc is seeing a modest upward move in after-market trading, currently near the upper end of its one-month range.

16.09.2026 г., 20:10 ч. UTC

Savara Inc shares fell sharply today, continuing a decline since Tuesday and trading significantly below its 20-day moving average.

15.09.2026 г., 20:07 ч. UTC

Savara Inc shares are lower, impacted by a sharp decline in the NY Empire State Manufacturing Index and rising oil prices amid broader market weakness.

11.09.2026 г., 20:08 ч. UTC

Savara Inc. shares are trading lower today, continuing a decline since Thursday's close amid a broader market downturn.

10.09.2026 г., 20:03 ч. UTC

Savara Inc. shares are lower today, reflecting broader market conditions amid the European Central Bank's recent interest rate hike and inflation projections.

Сравнение с други в отрасъла

Ценова промяна

Savara Inc Прогноза

Ценова цел

By TipRanks

150.74% нагоре

12-месечна прогноза

Среден 11.333 USD  150.74%

Висок 16 USD

Нисък 9 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Savara Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

6 ratings

6

Купи

0

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Savara Inc

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania.
help-icon Live chat